Latest Bone tumor Stories
Washington University in St. Louis Cancer drugs should kill tumors, not encourage their spread. But new evidence suggests that an otherwise promising class of drugs may actually increase the risk of tumors spreading to bone, according to researchers at Washington University School of Medicine in St. Louis. The drugs, IAP antagonists, block survival signals that many cancer cells rely on to stay alive. Working in mice, the investigators found that targeting the same protein that makes...
Ewing’s sarcoma is a bone cancer commonly diagnosed in about 250 U.S. teenagers per year.
New research shows when it comes to bone-cancer-related fractures, pain can be reduced by drug treatment, but no one drug is superior.
Bone cancer-related fractures and pain can be reduced by drug treatment, but no one drug is superior.
Researchers found that administering a common chemotherapy drug before bone tumors took root actually fertilized the bone marrow, enabling cancer cells, once introduced, to seed and grow more easily.
Many children with the bone cancer, osteosarcoma, die after the tumor spreads to their lungs.
The International and American Associations for Dental Research have released in its Journal of Dental Research a study that investigated bone fluoride levels in individuals with osteosarcoma, which is a rare, primary malignant bone tumor that is more prevalent in males.
In a rare and medically remarkable operation, a multi-disciplinary team of surgeons at the Ohio State University Comprehensive Cancer Center â€“ Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC â€“ James) removed the left leg, hip and pelvis of a cancer patient, and used the healthy, living bones from his amputated leg to completely rebuild the connection between his spine and remaining right pelvis to support a high-tech prosthetic leg.
James C. Wittig, M.D. and colleagues will conduct a total of eight research presentations at the upcoming 96th Annual Clinical Congress of the American College of Surgeons and the 65th Annual Meeting of the American Society for Surgery of the Hand. Dr. Wittig, an orthopedic oncologist with extensive experience in performing limb-sparing surgeries, is Chief of the Division of Skin and Sarcoma Cancer of the John Theurer Cancer Center at Hackensack University Medical Center.
HACKENSACK, N.J., Oct. 4 /PRNewswire/ -- James C. Wittig, M.D. and colleagues will conduct a total of eight research presentations at the upcoming 96th Annual Clinical Congress of the American College of Surgeons and the 65th Annual Meeting of the American Society for Surgery of the Hand. Dr.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.